Leslie S. Kean, MD, PhD^1,2,3, Linda J Burns, MD^4*, Tzuyung Douglas Kou^5*, Christopher Bond^6*, Roxanne Kapikian^6,7*, Karissa Lozenski^6*, Xiao-Ying Tang, MPH^4*, Mei-Jie Zhang, PhD^4*, Michael T Hemmer^8,9*, Sean E Connolly^6*, Martin Polinsky^6*, Andres Gomez^6* and Marcelo C Pasquini, MD, MS⁴

¹Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Pediatrics, Harvard Medical School, Boston
⁴Center for International Blood and Marrow Transplant Research, Milwaukee, WI
⁵Bristol Myers Squibb (at the time of analysis), Princeton, NJ
⁶Bristol Myers Squibb, Princeton, NJ
⁷Cytel Inc., Waltham, MA
⁸Center for International Blood and Marrow Transplant Research (at the time of analysis), Milwaukee, WI
⁹Kite Pharma, Santa Monica, CA

Franco Locatelli, MD¹, Hyoung Jin Kang, MD, PhD², Bénédicte Bruno, MD^3*, Virginie Gandemer^4*, Fanny Rialland, MD^5*, Maura Faraci, MD^6*, Yoshiyuki Takahashi, MD, PhD^7*, Katsuyoshi Koh, MD^8*, Henrique Bittencourt, MD, PhD⁹, Grace Cleary, MPharm^10*, Christine Rosko, BSN^11*, Pantelia Roussou, PhD^12*, Annie St. Pierre, PhD^13*, Anirudh Prahallad, PhD^12* and Cristina Díaz-de-Heredia, MD, PhD^14*

¹IRCCS Ospedale Pediatrico Bambino Gesú, Catholic University of the Sacred Heart, Rome, Italy
²Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children’s Hospital, Seoul, South Korea
³Pediatric Hematology, Hôpital Jeanne de Flandre, CHRU de Lille, Lille, France
⁴University Hospital of Rennes, Rennes, France
⁵Service Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, Nantes University Hospital, Nantes, France
⁶HSCT Unit, Istituto Giannina Gaslini, Genova, Italy
⁷Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁸Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
⁹Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada
¹⁰Novartis Ireland Limited, Dublin, Ireland
¹¹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹²Novartis Pharma AG, Basel, Switzerland
¹³Novartis Pharma AG, Basel, Maryland, Switzerland
¹⁴Hospital Universitari Vall d’Hebron, Barcelona, Spain

Vijaya Raj Bhatt, MBBS, MS^1*, Valerie K Shostrom, MS^2*, Ayman Saad, MD, MSc^3*, Betty K. Hamilton, MD⁴, Krishna Gundabolu, MBBS⁵, Lori Maness, MD⁵, Virender Kumar^6*, Ram I Mahato^7*, Lynette M. Smith, PhD^8*, Taiga Nishihori, MD⁹ and Stephanie J. Lee, MD, MPH¹⁰

¹The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
²Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE
³James Cancer Center, Ohio State Medical Center, Columbus, OH
⁴Cleveland Clinic Foundation, Cleveland, OH
⁵Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
⁶University of Nebraska Medical Center, Omaha
⁷University of Nebraska Medical Center, Omaha, NE
⁸Department of Biostatistics, University fo Nebraska Medical Center, Omaha, NE
⁹Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
¹⁰Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Liping Dou^1*, Yanli Zhao^2*, Lei Deng^3*, Fang Zhou, PhD^3*, Nan Wang^1*, Xiangshu Jin^1*, Fei Li^1*, Liangding Hu^1* and Daihong Liu, MD¹

¹Department of Hematology, Chinese PLA General Hospital, Beijing, China
²Department of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
³Department of Hematology, The 960th Hospital of the People's Liberation Army, Jinan, China

Rongrong Liu, PhD, MD^1*, Meiqing Wu, PhD, MD^2*, Qiaochuan Li, PhD, MD^3*, Lianjin Liu, MD^3*, Chunjie Qin, MD^4*, Hong Chen, PhD, MD^5*, Lingling Shi, PhD, MD^3*, Gaohui Yang, PhD, MD^6*, Zeyan Shi, MD^3*, Zhongqing Li, PhD, MD^3*, Zhenbin Wei, MD^7*, Beicai Liu, MD^3*, Jing Fan^3*, Yinghua Chen^8*, Xuemei Zhou^3*, Zhongming Zhang, PhD, MD^3*, Yongrong Lai, PhD, MD^2* and Qifa Liu, MD⁹

¹GuangXi Medical University, Nanning, CHN
²Heamatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
³The First Affiliated Hospital of Guangxi Medical University, Nanning, China
⁴Heamatology, Liuzhou Worker’s Hospital, Liuzhou, CHN
⁵Liuzhou Worker’s Hospital, Liuzhou, China
⁶The First Affiliated Hospital of Guangxi Medical University, Nanning, CHN
⁷The First Affiliated Hospital of Guangxi Medical University, Nanning City, CHN
⁸The First Affiliated Hospital of Guangxi Medical University, Nanning, OH, China
⁹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Bidesh Kumar Patel, MD^1*, Michael J Raabe^1*, Vikram Deshpande, MBBS^2*, David T Ting, MD^1*, Yi-Bin Chen, MD, MS³ and Zachariah Defilipp, MD³

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Massachusetts General Hospital, Boston, MA
³Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA